Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Avita Medical Ltd ADR (RCEL)

Avita Medical Ltd ADR (RCEL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 771,680
  • Shares Outstanding, K 82,621
  • Annual Sales, $ 5,510 K
  • Annual Income, $ -24,750 K
  • 60-Month Beta 1.31
  • Price/Sales 148.42
  • Price/Cash Flow N/A
  • Price/Book 10.00

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.51 +9.75%
on 01/31/20
11.07 -15.63%
on 02/19/20
-0.05 (-0.53%)
since 01/24/20
3-Month
7.37 +26.73%
on 12/11/19
11.07 -15.63%
on 02/19/20
+1.61 (+20.83%)
since 11/22/19
52-Week
1.87 +399.47%
on 03/04/19
11.07 -15.63%
on 02/19/20
+7.40 (+381.44%)
since 02/22/19

Most Recent Stories

More News
AVITA Medical Half-Year Financial Report for Fiscal 2020

AVITA Medical Limited (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, announced that it filed...

AVMXY : 7.8900 (+9.13%)
AVH : 4.52 (-6.22%)
RCEL : 9.34 (-5.66%)
AVITA Medical to Present at the Cowen 40th Annual Health Care Conference

AVITA Medical (ASX: AVH) (NASDAQ: RCEL), a global regenerative medicine company, announced that management will present at the Cowen 40th Annual Health Care Conference in Boston. The presentation is being...

AVMXY : 7.8900 (+9.13%)
AVH : 4.52 (-6.22%)
RCEL : 9.34 (-5.66%)
Community Health Systems (CYH) in Focus: Stock Moves 5.9% Higher

Community Health Systems (CYH) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

CYH : 6.02 (-16.16%)
RCEL : 9.34 (-5.66%)
Biotech Rally Sends Nasdaq to 9000: ETFs in Focus

Some biotech stocks have contributed materially to the Nasdaq's 1000-point gain since Aug 27, 2018 and helped it notch a record 9,000 on Dec 26.

CSCO : 44.00 (-4.96%)
AMZN : 2,009.29 (-4.14%)
FB : 200.72 (-4.50%)
GOOG : 1,421.59 (-4.28%)
AAPL : 298.18 (-4.75%)
MSFT : 170.89 (-4.31%)
BBC : 36.27 (-3.86%)
XPH : 44.87 (-3.15%)
AXSM : 88.51 (-2.88%)
INTC : 61.76 (-4.01%)
CNST : 37.35 (-0.66%)
SAVA : 7.37 (-3.28%)
KOD : 60.78 (+4.29%)
RCEL : 9.34 (-5.66%)
5 Top-Ranked ADRs That More Than Doubled the S&P 500 in 2019

Though international markets trailed the U.S. market in 2019, there are hidden gems that crushed the S&P 500 this year on stock-specific strength.

VIPS : 12.80 (-4.26%)
EFA : 65.53 (-4.00%)
VGK : 55.55 (-4.31%)
AIA : 62.34 (-3.38%)
EEM : 41.67 (-3.74%)
AVDL : 10.64 (+13.19%)
SBGL : 12.26 (-2.93%)
EDU : 134.78 (-2.20%)
RCEL : 9.34 (-5.66%)
FLN : 21.15 (-3.00%)
Small Gains Still Bring New Records

Small Gains Still Bring New Records

CDAY : 74.05 (-1.20%)
WWE : 48.73 (-2.99%)
ERI : 62.99 (-7.53%)
WYNN : 120.17 (-6.08%)
GH : 84.29 (-5.09%)
NVTA : 22.10 (-4.33%)
KERN : 7.12 (-2.20%)
RCEL : 9.34 (-5.66%)
AVITA Medical Added to S&P/ASX 200 Index

AVITA Medical (ASX: AVH) (NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, announced today that the company...

AVMXY : 7.8900 (+9.13%)
AVH : 4.52 (-6.22%)
RCEL : 9.34 (-5.66%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade RCEL with:

Business Summary

Avita Medical Limited operates as a medical technology company. The company develops and distributes products in Regenerative and Respiratory Medicine. Avita's regenerative and tissue-engineered products provide revolutionary solutions utilizing the patient's own skin and the regenerative capability...

See More

Key Turning Points

2nd Resistance Point 9.83
1st Resistance Point 9.59
Last Price 9.34
1st Support Level 9.14
2nd Support Level 8.93

See More

52-Week High 11.07
Last Price 9.34
Fibonacci 61.8% 7.56
Fibonacci 50% 6.47
Fibonacci 38.2% 5.38
52-Week Low 1.87

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar